Roivant Sciences (ROIV) Invested Capital (2021 - 2024)
Roivant Sciences' Invested Capital was $6.1 billion in fiscal Q1 2025 (quarter ended Jun 30, 2024), up 295.8% from $1.54 billion a year earlier but down 8.3% from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Invested Capital (2021 - 2024) Analysis & Trends
For FY2024 (ended Mar 31, 2024), Invested Capital at Roivant Sciences came in at $6.65 billion, up 267.7% from FY2023.
- Invested Capital shows a three-year compound annual growth rate of 44.4% (FY2021 to FY2024).
- In earlier fiscal years, Invested Capital was $1.81 billion in FY2023 (-19.6%), $2.25 billion in FY2022 (+1.8%) and $2.21 billion in FY2021.
- Quarterly Invested Capital has moved between $1.54 billion (fiscal Q2 2024) and $6.8 billion (fiscal Q3 2024) over five years.
- Compared with a year earlier, Invested Capital has increased for three straight quarters, with growth averaging 96.3% over the last eight quarters.
- The best year-over-year quarter for Invested Capital over five years was fiscal Q3 2024 (growth of 319.3%); the worst was fiscal Q2 2023 (a decline of 35.2%).
- Per Business Quant data, ROIV's Invested Capital in the three fiscal quarters before Q1 2025 was $6.65 billion (Q4 2024), $6.8 billion (Q3 2024) and $1.54 billion (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Roivant Sciences | 26.43 Bn | 27.12 Bn | 1.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 6.10 Bn |
| Mar 31, 2024 | 6.65 Bn |
| Dec 31, 2023 | 6.80 Bn |
| Sep 30, 2023 | 1.54 Bn |
| Jun 30, 2023 | 1.54 Bn |
| Mar 31, 2023 | 1.81 Bn |
| Dec 31, 2022 | 1.62 Bn |
| Sep 30, 2022 | 1.70 Bn |
| Jun 30, 2022 | 1.79 Bn |
| Mar 31, 2022 | 2.25 Bn |
| Dec 31, 2021 | 2.45 Bn |
| Sep 30, 2021 | 2.63 Bn |
| Jun 30, 2021 | 2.14 Bn |
| Mar 31, 2021 | 2.21 Bn |
API Access
Roivant Sciences Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();